Hospitalization costs for children with pneumonia in Shanghai, China from 2019 to 2020

Abstract

Pneumonia is the leading cause of death in children under 5 years of age worldwide. In this study, we primarily analyzed the hospitalization costs for children diagnosed with pneumonia in one of the leading public hospitals in Shanghai, China. Furthermore, factors affecting the hospitalization costs for children with pneumonia were evaluated. Data on case diagnosis, hospitalization time, age and various hospitalization expenses were collected. Total hospitalization expense for the 149 cases was $177,750, with an average total cost of $1,193 per person and an average out-of-pocket cost of $642. The highest per capita expenses included fees for laboratory diagnosis ($418), general medical service ($235), western medicine ($253), and antibacterial drugs ($158). The leading diagnosis was bronchopneumonia, with 68 (46%) cases, an average hospital stays of 7.4 days, and average hospitalization expenses of $1,068. Considering the high burden of pneumonia in children, hospitals and governments must make more reasonable use of limited resources of the medical system. At the same time, various types of medical insurance should be added into the children’s medical security system, encourage vaccination with pneumonia vaccines (13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine), and ensure that more children benefit from the vaccine by including it in the national immunization program.

Understanding vaccine hesitancy with PCV13 in children: Results of a survey in Shanghai, China

“…As such, the price of PCV13 is substantially higher than the cost-effective price, potentially leading to some level of vaccine hesitancy. On the other hand, the daily hospitalization cost for children under 5 years old admitted with pneumonia was $150, and the daily hospitalization cost for severe pneumonia was $241 in Shanghai, China [ 21 ]. Furthermore, children vaccinated with at least one dose of pneumonia vaccine had lower hospitalization costs than unvaccinated children [ 22 ].…”

The Relationship of Serum Zinc Level in Patients with Pneumonia and Its Effect on Their Outcome

“…In 2019, pneumonia claimed the lives of 740,180 children worldwide. This disease poses a significant public health challenge, impeding healthy childhood development and imposing a substantial economic burden on patients, families, and society, exceeding that of other common pediatric illnesses [1] .…”

Dihydrokaempferol attenuates LPS-induced inflammation and apoptosis in WI-38 cells

“…3,4 According to the World Health Organization (WHO) data, pneumonia is responsible for more than 900,000 child deaths globally. 5 Infantile pneumonia is still a significant clinical and public health problem. 6 It is still imperative to identify reliable biomarkers associated with infantile pneumonia to decrease the incidence and mortality of this disease.…”